Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Actin vs Boston Medical Group

Actin
Graded #355

Lower grade

vs+11.100000000000009
Boston Medical Group
Graded #113

Higher grade

The verdict

Boston Medical Group takes it — 69.9/100 to 58.8/100.

Boston Medical Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established medical group offering a 3-month semaglutide weight loss program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBoston Medical Group +27
59
86
Dose & formulationEven
52
52
Clinical oversightBoston Medical Group +10
79
89
Labs & monitoringBoston Medical Group +1
52
53
FulfillmentBoston Medical Group +3
62
65
Contract termsBoston Medical Group +22
33
55
Actin · left barBoston Medical Group · right bar

The numbers

MetricActinBoston Medical Group
WeighScore58.8/10069.9/100
GradeCC
Scorecard rank#355#113
Semaglutide$169/mo (compounded)$66/mo (starting dose, compounded)
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published7 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Actin

Graded #355 · C

Strengths

  • Semaglutide paired with B12 for added energy support
  • Transparent pricing — exact cost shown upfront with no hidden fees
  • Competitive pricing from $116/mo on the 6-month plan ($169/mo month-to-month)

Where it loses points

  • Semaglutide only — no tirzepatide or liraglutide
  • No visible LegitScript or PCAB accreditation
  • States served not disclosed
  • Broad platform spanning hormones, sexual wellness, and hair health
Boston Medical Group

Graded #113 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard